These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 576979

  • 1. Cefazolin and Staphylococcus aureus endocarditis.
    Kaye D, Hewitt W, Remington JS, Turck M.
    JAMA; 1977 Jun 13; 237(24):2601. PubMed ID: 576979
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of staphylococcal endocarditis.
    Bryant RE, Alford RH.
    JAMA; 1978 Mar 20; 239(12):1130-1. PubMed ID: 628061
    [No Abstract] [Full Text] [Related]

  • 3. Unsuccessful treatment of staphylococcal endocarditis with cefazolin.
    Bryant RE, Alford RH.
    JAMA; 1977 Feb 07; 237(6):569-70. PubMed ID: 576284
    [Abstract] [Full Text] [Related]

  • 4. Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.
    Carrizosa J, Santoro J, Kaye D.
    Antimicrob Agents Chemother; 1978 Jan 07; 13(1):74-7. PubMed ID: 626493
    [Abstract] [Full Text] [Related]

  • 5. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1980 Oct 07; 18(4):562-5. PubMed ID: 7447418
    [Abstract] [Full Text] [Related]

  • 6. Cefazolin versus cephalothin in beta-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model.
    Carrizosa J, Kobasa WD, Snepar R, Kaye KM, Kaye D.
    J Antimicrob Chemother; 1982 May 07; 9(5):387-93. PubMed ID: 6980218
    [No Abstract] [Full Text] [Related]

  • 7. Cefazolin therapy for Staphylococcus aureus bacteremia.
    Fernández-Guerrero ML, de Górgolas M.
    Clin Infect Dis; 2005 Jul 01; 41(1):127. PubMed ID: 15937778
    [No Abstract] [Full Text] [Related]

  • 8. Staphylococcus lugdunensis endocarditis after angiography.
    Polenakovik H, Herchline T, Bacheller C, Bernstein J.
    Mayo Clin Proc; 2000 Jun 01; 75(6):656-7. PubMed ID: 10852432
    [No Abstract] [Full Text] [Related]

  • 9. Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue.
    Nannini EC, Singh KV, Murray BE.
    Clin Infect Dis; 2003 Nov 01; 37(9):1194-8. PubMed ID: 14557964
    [Abstract] [Full Text] [Related]

  • 10. Cefazolin versus cloxacillin in methicillin-susceptible Staphylococcus aureus endocarditis: Too good to be true? Authors' reply.
    Herrera-Hidalgo L, de Alarcón A.
    Int J Infect Dis; 2024 May 01; 142():106979. PubMed ID: 38401779
    [No Abstract] [Full Text] [Related]

  • 11. Daptomycin cure after cefazolin treatment failure of Methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line.
    Cunha BA, Hamid N, Kessler H, Parchuri S.
    Heart Lung; 2005 May 01; 34(6):442-7. PubMed ID: 16324966
    [Abstract] [Full Text] [Related]

  • 12. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
    Goldman PL, Petersdorf RG.
    J Infect Dis; 1980 Mar 01; 141(3):331-7. PubMed ID: 6965978
    [Abstract] [Full Text] [Related]

  • 13. Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
    Boscia JA, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1988 Feb 01; 32(2):262-4. PubMed ID: 3163241
    [Abstract] [Full Text] [Related]

  • 14. Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
    Miller WR, Singh KV, Arias CA, Murray BE.
    Antimicrob Agents Chemother; 2018 Nov 01; 62(11):. PubMed ID: 30150459
    [Abstract] [Full Text] [Related]

  • 15. Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis.
    Quinn EL, Pohlod D, Madhavan T, Burch K, Fisher E, Cox F.
    J Infect Dis; 1973 Oct 01; 128():Suppl:S386-9. PubMed ID: 4744022
    [No Abstract] [Full Text] [Related]

  • 16. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.
    Kernodle DS, Classen DC, Burke JP, Kaiser AB.
    JAMA; 1990 Feb 16; 263(7):961-6. PubMed ID: 2299764
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of cefazolin in the treatment of bacterial endocarditis and bacteremia.
    Reinarz JA, Kier CM, Guckian JC.
    J Infect Dis; 1973 Oct 16; 128():Suppl:S392-6. PubMed ID: 4147580
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of bacterial endocarditis 1976.
    Benn R.
    Drugs; 1976 Nov 16; 12(5):374-80. PubMed ID: 824117
    [No Abstract] [Full Text] [Related]

  • 19. 'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study'-author's reply.
    Lecomte R, Deschanvres C, Coudol S, Wargny M, Camou F, Boutoille D.
    Clin Microbiol Infect; 2021 Aug 16; 27(8):1180-1181. PubMed ID: 33813113
    [No Abstract] [Full Text] [Related]

  • 20. Re: 'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study' by Lecomte et al.
    Buis DTP.
    Clin Microbiol Infect; 2021 Aug 16; 27(8):1179. PubMed ID: 33581355
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.